Quinta Nfor
Nurse Practitioner · New Berlin, WINPI 1164808317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 564 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 564 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- AbbVie$1K
- Boehringer Ingelheim$760
- Amneal Pharmaceuticals LLC$652
- AstraZeneca$547
- plus $6K from 39 others
What the payments were for
- Food & beverage$11,165100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,185 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $15,951 |
| TradjentaLinagliptin | 14 | $9,383 |
| FarxigaDapagliflozin Propanediol | 12 | $7,216 |
| MyrbetriqMirabegron | 13 | $5,496 |
| RytaryCarbidopa/Levodopa | 12 | $4,770 |
| Novolog FlexpenInsulin Aspart | 31 | $4,427 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 11 | $1,099 |
| Atorvastatin Calcium | 82 | $1,088 |
| Telmisartan | 13 | $1,086 |
| FenofibrateFenofibrate Nanocrystallized | 18 | $982 |
| Levothyroxine Sodium | 63 | $880 |
| Amlodipine Besylate | 93 | $857 |
| Gabapentin | 67 | $787 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 22 | $632 |
| Losartan Potassium | 54 | $588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $304 | $15,95128 claims |
| Boehringer IngelheimTradjenta | $760 | $9,38314 claims |
| AstraZenecaFarxiga | $547 | $7,21612 claims |
| Amneal Pharmaceuticals LLCRytary, Levothyroxine Sodium | $652 | $5,65075 claims |
| Astellas Pharma US IncMyrbetriq | $174 | $5,49613 claims |
| Almatica Pharma LLCSertraline Hcl | $24 | $48247 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in New Berlin
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Kari FisherPrairie du Sac$57K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.